News Agency
The Times

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

  • Written by PR Newswire
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Christopher W. Slavinsky as Chief Business Development and Legal Officer.

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal OfficerHanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

"Chris brings a wealth of expertise...

Read more: HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion